Form 4: Revelation Biosciences Director Receives Stock Grant
Insider Transaction (Form 4)
Lakhmir S Chawla, a Director of Revelation Biosciences, Inc., received 32,011 shares of common stock on August 17, 2026.
Summary
- Grant/award: acquired 32,011 Common Stock on August 17, 2026; holds 44,169 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Lakhmir S Chawla — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Grant/award | Common Stock | 32,011 | — | — | 44,169 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Grant/award (32,011 shares) |
Keywords
insider transaction, Form 4, REVB, REVELATION BIOSCIENCES, INC., neutral, Lakhmir S Chawla
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.